Adapalene Gel 0.3% in the Treatment of Atrophic Acne Scars

Completed · Phase 2

Conditions studied: Acne Scars

In brief

The purpose of this study is to assess the efficacy and safety of Adapalene Gel 0.3% in the treatment of atrophic acne scars.

Key facts

Study ID

NCT01213199

Run by

Galderma R&D

People needed

20

Starts

2011-03-01

Expected to finish

2012-09-01

Last updated by the study team

2021-02-18

Who can join

Age: 18 and older, up to 50. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Male or female subjects of any race, aged 18 to 50 years inclusive
• Subjects with a past history of acne and with moderate to severe facial atrophic acne scars

You may not qualify if…

• Subjects with active inflammatory acne lesions
• Subjects with hypertrophic acne scars

Where it is running

• Manisha PATEL — Baltimore, Maryland, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.